CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer
Conditions: Locally Advanced Rectal Cancer; Neoadjuvant Therapy Interventions: Drug: PD-1 antibody; Drug: Capecitabine; Radiation: Short-course radiotherapy Sponsors: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Rectal Cancers | Research | Xeloda